GILD

Q: What is the price of Gilead Sciences (GILD) today?

The price of Gilead Sciences (GILD) today is US$ 117,18, with a variation of 42.52% compared to the last year. The price of Gilead Sciences (GILD) started the year trading around US$ 92,37 and today it is at US$ 117,18. Follow the real-time price chart, the historical price of Gilead Sciences (GILD), and stock data from Ibovespa and international markets.

Q: When does Gilead Sciences (GILD) pay dividends?

Gilead Sciences (GILD) distributed dividends in the last year,in the months of March, June and September totaling US$ 2,37. The Dividend Yield for the last 12 months is 2,79%.

Q: Gilead Sciences (GILD) is it worth it?

Currently, Gilead Sciences (GILD) is priced at US$ 117,18, with a P/E of 19,99%, representing a deviation of 16,11% from its historical average P/E. In the last year, the stock showed a variation of 42.52% in its price and distributed US$ 2,37 in dividends, resulting in a Dividend Yield of 2,79%. The total shareholder return was 42,52%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Gilead Sciences (GILD)?

Investing in stocks of Gilead Sciences (GILD) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Gilead Sciences (GILD) yield today?

The yield of Gilead Sciences (GILD) was 2,38% in the last month, 42,52% in the last year and 121,21% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 3,14 in dividends, um Dividend Yield de 2,79%.If you wanted to buy 100 stocks of Gilead Sciences (GILD) today, the total investment would be US$ 11.718,00, based on the current price of US$ 117,18.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 16.700,49In 5 years: US$ 25.921,39In 10 years: 19.863,18It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Gilead Sciences Inc.

Price

US$ 117,18

variation (12m)

42,52%

p/l

19,99

p/vp

7,16

DIVIDEND YIELD

2,79%

price GILD

BVMF

GILD

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of GILD

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

2,38%

3 months

7,62%

1 year

42,52%

2 years

63,81%

5 years

121,21%

10 years

69,51%

real profitability

profitability minus inflation.

1 month

2,38%

3 months

7,22%

1 year

36,27%

2 years

49,51%

5 years

63,47%

10 years

1,49%

Indicators GILD

check out the fundamentals of Gilead Sciences shares

P/E

19,99

Sector: -3,47 Industry: -3,47

P/SALES RATIO (PSR)

4,94

Sector: -4,23 Industry: -4,23

P/BV

7,16

Sector: 1,89 Industry: 1,89

DIVIDEND YIELD (DY)

2,79%

Sector: - Industry: -

ROA

12,59%

Sector: -63,87% Industry: -63,87%

ROE

35,82%

Sector: -70,87% Industry: -70,87%

ROIC

18,70%

Sector: -2.084,36% Industry: -2.084,36%

NET MARGIN

24,71%

Sector: -41,75% Industry: -41,75%

GROSS MARGIN

78,44%

Sector: 38,19% Industry: 38,19%

OPERATING MARGIN

36,55%

Sector: -41,04% Industry: -41,04%

P/EBITDA

13,51

Sector: -3,65 Industry: -3,65

P/EBIT

14,48

Sector: -3,64 Industry: -3,64

P/ASSET

2,52

Sector: 1,41 Industry: 1,41

BVPS

15,73

Sector: 1,84 Industry: 1,84

EPS

5,64

Sector: -2,20 Industry: -2,20

EQUITY / ASSETS

0,35

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

2,00%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

0,00%

Sector: - Industry: -

FAIR PRICE OF Gilead Sciences ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 117,18

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-61,87%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

GILD indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	17,80	5,78	32,50%	2,69%	US$ 453,87 B	27,75%
PFE	16,92	1,75	10,33%	6,25%	US$ 155,60 B	15,13%
ABBV	108,79	-2.966,40	-2.726,81%	2,79%	US$ 409,36 B	6,45%
NVO	16,20	10,21	62,99%	2,83%	US$ 265,17 B	34,74%
MRK	12,67	4,56	36,03%	3,59%	US$ 223,87 B	28,16%
AZN	28,39	5,90	20,79%	1,83%	US$ 264,46 B	16,23%
BMY	17,97	5,29	29,44%	5,41%	US$ 92,49 B	10,71%
ZTS	24,61	13,09	53,20%	1,32%	US$ 65,16 B	28,00%
HALO	14,26	25,08	175,93%	0,00%	US$ 8,35 B	48,21%
REGN	13,97	2,10	15,06%	0,44%	US$ 63,00 B	31,83%
AMGN	30,70	21,58	70,29%	3,15%	US$ 160,26 B	14,67%
VRTX	28,59	6,03	21,11%	0,00%	US$ 103,65 B	31,22%
MCK	24,89	-106,90	-429,55%	0,40%	US$ 92,26 B	0,97%
CAH	26,56	-13,96	-52,54%	1,31%	US$ 36,76 B	0,60%
ADMA	17,05	8,87	52,03%	0,00%	US$ 3,53 B	43,51%
BIIB	13,23	1,33	10,08%	0,00%	US$ 23,50 B	17,46%
HRMY	8,91	2,01	22,58%	0,00%	US$ 1,55 B	22,19%

comparison of GILD with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History GILD

current DY: 2,79%

5-year average DY: 4,24%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	15/09/2025	29/09/2025	0,79000000
Dividends	13/06/2025	27/06/2025	0,79000000
Dividends	14/03/2025	28/03/2025	0,79000000
Dividends	13/12/2024	30/12/2024	0,77000000
Dividends	13/09/2024	27/09/2024	0,77000000
Dividends	14/06/2024	27/06/2024	0,77000000
Dividends	15/03/2024	28/03/2024	0,77000000
Dividends	15/12/2023	28/12/2023	0,75000000
Dividends	15/09/2023	28/09/2023	0,75000000
Dividends	15/06/2023	29/06/2023	0,75000000
Dividends	15/03/2023	30/03/2023	0,75000000
Dividends	15/12/2022	29/12/2022	0,73000000
Dividends	15/09/2022	29/09/2022	0,73000000
Dividends	15/06/2022	29/06/2022	0,73000000
Dividends	15/03/2022	30/03/2022	0,73000000
Dividends	15/12/2021	30/12/2021	0,71000000
Dividends	15/09/2021	29/09/2021	0,71000000
Dividends	15/06/2021	29/06/2021	0,71000000
Dividends	15/03/2021	30/03/2021	0,71000000
Dividends	15/12/2020	30/12/2020	0,68000000
Dividends	15/09/2020	29/09/2020	0,68000000
Dividends	12/06/2020	29/06/2020	0,68000000
Dividends	13/03/2020	30/03/2020	0,68000000
Dividends	13/12/2019	30/12/2019	0,63000000
Dividends	13/09/2019	27/09/2019	0,63000000
Dividends	14/06/2019	27/06/2019	0,63000000
Dividends	15/03/2019	28/03/2019	0,63000000
Dividends	14/12/2018	28/12/2018	0,57000000
Dividends	14/09/2018	27/09/2018	0,57000000
Dividends	15/06/2018	28/06/2018	0,57000000
Dividends	16/03/2018	29/03/2018	0,57000000
Dividends	15/12/2017	28/12/2017	0,52000000
Dividends	15/09/2017	28/09/2017	0,52000000
Dividends	16/06/2017	29/06/2017	0,52000000
Dividends	16/03/2017	30/03/2017	0,52000000
Dividends	15/12/2016	29/12/2016	0,47000000
Dividends	16/09/2016	29/09/2016	0,47000000
Dividends	16/06/2016	29/06/2016	0,47000000
Dividends	16/03/2016	30/03/2016	0,43000000
Dividends	16/12/2015	30/12/2015	0,43000000
Dividends	16/09/2015	29/09/2015	0,43000000
Dividends	16/06/2015	29/06/2015	0,43000000

ABOUT THE COMPANY Gilead Sciences

Gilead Sciences Inc.

Average user rating I10

4.0 (64 people)

Estados Unidos

38 years

Foundation: 1987

1992

Year of debut on the stock exchange - 33 years

13.600

Employees

The Company Gilead Sciences Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 140,30 Billions, having a net worth of $ 19,59 Billions.

With a total of 13.600 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 28,40 Billions, which generated a profit in the amount of $ 7,02 Billions.

As for its main indicators, the Company has a P/E ratio of 19,99, a P/BV ratio of 7,16 and in the last 12 months the dividend yield of GILD was at 2,79%.

The Company is traded internationally through the ticker GILD.

Market value

US$ 140,30 Billions

Net worth

US$ 19,59 Billions

US$ 19.590.000.000,00

Assets

US$ 55,72 Billions

US$ 55.721.000.000,00

Total Number of Shares

1,25 Billion

1.245.000.000

Average Daily Trading Volume

US$ 6,95 Milhões

US$ 6.948.652,00

Sector

Health Care

Industry

Biotechnology

GILD

GILD revenue and profits

GILD results

DRAG THE FRAME TO SEE MORE DATA

GILD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 763,55 51,69% (12M)

P/L

24,89

0,40%

ROE

-429,55%

P/VP

-106,90

CAH - Cardinal Health

US$ 156,88 42,09% (12M)

P/L

26,56

1,31%

ROE

-52,54%

P/VP

-13,96

JNJ - Johnson & Johnson

US$ 190,72 21,94% (12M)

P/L

17,80

2,69%

ROE

32,50%

P/VP

5,78

MRK - Merck & Co.

US$ 85,99 --18,73% (12M)

P/L

12,67

3,59%

ROE

36,03%

P/VP

4,56

ABBV - AbbVie

US$ 230,50 23,82% (12M)

P/L

108,79

2,79%

ROE

-2.726,81%

P/VP

-2.966,40

PFE - Pfizer

US$ 24,78 --8,77% (12M)

P/L

16,92

6,25%

ROE

10,33%

P/VP

1,75

AZN - AstraZeneca

US$ 84,53 11,61% (12M)

P/L

28,39

1,83%

ROE

20,79%

P/VP

5,90

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 763,55 51,69% (12 M)

P/L

24,89

0,40%

ROE

-429,55%

P/VP

-106,90

CAH - Cardinal Health

US$ 156,88 42,09% (12 M)

P/L

26,56

1,31%

ROE

-52,54%

P/VP

-13,96

JNJ - Johnson & Johnson

US$ 190,72 21,94% (12 M)

P/L

17,80

2,69%

ROE

32,50%

P/VP

5,78

MRK - Merck & Co.

US$ 85,99 --18,73% (12 M)

P/L

12,67

3,59%

ROE

36,03%

P/VP

4,56

ABBV - AbbVie

US$ 230,50 23,82% (12 M)

P/L

108,79

2,79%

ROE

-2.726,81%

P/VP

-2.966,40

PFE - Pfizer

US$ 24,78 --8,77% (12 M)

P/L

16,92

6,25%

ROE

10,33%

P/VP

1,75

AZN - AstraZeneca

US$ 84,53 11,61% (12 M)

P/L

28,39

1,83%

ROE

20,79%

P/VP

5,90

Frequently Asked Questions

What is the price of Gilead Sciences (GILD) today?

The price of Gilead Sciences (GILD) today is US$ 117,18, with a variation of 42.52% compared to the last year. The price of Gilead Sciences (GILD) started the year trading around US$ 92,37 and today it is at US$ 117,18. Follow the real-time price chart, the historical price of Gilead Sciences (GILD), and stock data from Ibovespa and international markets.

When does Gilead Sciences (GILD) pay dividends?

Gilead Sciences (GILD) distributed dividends in the last year,in the months of March, June and September totaling US$ 2,37. The Dividend Yield for the last 12 months is 2,79%.

Gilead Sciences (GILD) is it worth it?

Currently, Gilead Sciences (GILD) is priced at US$ 117,18, with a P/E of 19,99%, representing a deviation of 16,11% from its historical average P/E. In the last year, the stock showed a variation of 42.52% in its price and distributed US$ 2,37 in dividends, resulting in a Dividend Yield of 2,79%. The total shareholder return was 42,52%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Gilead Sciences (GILD)?

Investing in stocks of Gilead Sciences (GILD) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Gilead Sciences (GILD) yield today?

The yield of Gilead Sciences (GILD) was 2,38% in the last month, 42,52% in the last year and 121,21% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 3,14 in dividends, um Dividend Yield de 2,79%.

If you wanted to buy 100 stocks of Gilead Sciences (GILD) today, the total investment would be US$ 11.718,00, based on the current price of US$ 117,18.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 16.700,49
In 5 years: US$ 25.921,39
In 10 years: 19.863,18

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

GILD

Gilead Sciences Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of GILD

check out the fundamentals of Gilead Sciences shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 2,79%

5-year average DY: 4,24%

type

date with

payment date

value

ABOUT THE COMPANY Gilead Sciences

Gilead Sciences Inc.

Estados Unidos

38 years

1992

13.600

PROFIT X PRICE GILD

GILD results

GILD cash flow

evolution of assets - GILD

GILD balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

Frequently Asked Questions